SEC Form D · filed April 28, 2025
Abrexa Pharmaceuticals, Inc
Offering
$23.0M
Sold
$23.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SAN DIEGO, CA
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (6)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗